Search research articles
Contact Us
Filters
Showing results (21-30 of 98) with videos related to
Page
of 10
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 7, 2018
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non-Small Cell Lung Cancer
Mahmoud Hashim, Boris M Pfeiffer, Robert Bartsch, et al.
Vaccine
|
December 11, 2012
Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model
Mustafa Bakir, Baudouin Standaert, Ozden Turel, et al.
Pharmacoeconomics
|
May 7, 2017
Defining and Measuring the Affordability of New Medicines: A Systematic Review
Fernando Antoñanzas, Robert Terkola, Paul M Overton, et al.
Vaccines
|
April 27, 2026
Potential Public Health and Economic Impact of the Next-Generation COVID-19 Vaccine mRNA-1283 in The Netherlands
Simon van der Pol, Ekkehard Beck, Tjalke Westra, et al.
American Journal of Epidemiology
|
June 30, 2020
On the Causal Interpretation of Rate-Change Methods: The Prior Event Rate Ratio and Rate Difference
Robertus van Aalst, Edward Thommes, Maarten Postma, et al.
Journal of Comparative Effectiveness Research
|
September 18, 2020
A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patients
Urbano Sbarigia, Talitha Vincken, Peter Wigfield, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 31, 2018
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Qi Cao, Erik Buskens, Hans L Hillege, et al.
Plos One
|
December 10, 2024
Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands
Bart Slob, Tanja Fens, Maaike Weersma, et al.
Pilot and Feasibility Studies
|
May 20, 2023
Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach
Paul Geerts, Job Eijsink, Albine Moser, et al.
Plos One
|
February 20, 2019
Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia
Riswandy Wasir, Sylvi Irawati, Amr Makady, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 98) with videos related to
Sort By:
Page
of 10
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 7, 2018
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non-Small Cell Lung Cancer
Mahmoud Hashim, Boris M Pfeiffer, Robert Bartsch, et al.
Vaccine
|
December 11, 2012
Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model
Mustafa Bakir, Baudouin Standaert, Ozden Turel, et al.
Pharmacoeconomics
|
May 7, 2017
Defining and Measuring the Affordability of New Medicines: A Systematic Review
Fernando Antoñanzas, Robert Terkola, Paul M Overton, et al.
Vaccines
|
April 27, 2026
Potential Public Health and Economic Impact of the Next-Generation COVID-19 Vaccine mRNA-1283 in The Netherlands
Simon van der Pol, Ekkehard Beck, Tjalke Westra, et al.
American Journal of Epidemiology
|
June 30, 2020
On the Causal Interpretation of Rate-Change Methods: The Prior Event Rate Ratio and Rate Difference
Robertus van Aalst, Edward Thommes, Maarten Postma, et al.
Journal of Comparative Effectiveness Research
|
September 18, 2020
A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patients
Urbano Sbarigia, Talitha Vincken, Peter Wigfield, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 31, 2018
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Qi Cao, Erik Buskens, Hans L Hillege, et al.
Plos One
|
December 10, 2024
Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands
Bart Slob, Tanja Fens, Maaike Weersma, et al.
Pilot and Feasibility Studies
|
May 20, 2023
Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach
Paul Geerts, Job Eijsink, Albine Moser, et al.
Plos One
|
February 20, 2019
Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia
Riswandy Wasir, Sylvi Irawati, Amr Makady, et al.
Page
of 10